Sound Shore Management TEVA-OLD trades
Harry Burn
Harry Burn Teva Pharma Industries Ltd ADR stake
total: 203
Trades details
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 8
- Held since:
- 2023 Q3
- Held for:
- 12 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Harry Burn doesn't hold any Teva Pharma Industries Ltd ADR (TEVA-OLD) shares. To date, the estimated cost basis is nearly $10.83 for "buy" trades and estimated average "sell" price is $26.31. Sound Shore Management first purchased TEVA-OLD in 2023 Q3, initially acquiring about 7.92M shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA-OLD), Sound Shore Management has made 12 more transactions.
When did Harry Burn sell Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Harry Burn sold off the entire Teva Pharma Industries Ltd ADR (TEVA-OLD) position in 2026 Q3.
When did Harry Burn buy Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Harry Burn first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2023 Q3 at the reported quarter-end price of $10.20 per share.
What's the cost basis of Sound Shore Management's TEVA-OLD stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) stake is around $10.83 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.83
- Weighted AVG sell price:
- $26.31
Harry Burn's historical trades in Teva Pharma Industries Ltd ADR
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
0.00%
|
0
|
$33.88
|
|
-100% (-3,804,497)
|
-3.97%
|
|
2026 Q2
|
3.97%
|
3,804,497
|
$33.88
|
$128,896,358
|
-2.09% (-81,186)
|
-0.09%
|
|
2026 Q1
|
3.92%
|
3,885,683
|
$30.12
|
$117,036,772
|
-9.84% (-424,223)
|
-0.41%
|
|
2025 Q4
|
4.28%
|
4,309,906
|
$31.21
|
$134,512,166
|
-23.68% (-1,337,543)
|
-1.38%
|
|
2025 Q3
|
3.77%
|
5,647,449
|
$20.20
|
$114,078,470
|
-3.40% (-199,063)
|
-0.14%
|
|
2025 Q2
|
3.34%
|
5,846,512
|
$16.76
|
$97,987,541
|
+7.23% (+394,423)
|
+0.23%
|
|
2025 Q1
|
2.94%
|
5,452,089
|
$15.37
|
$83,798,608
|
+14.23% (+679,377)
|
+0.37%
|
|
2024 Q4
|
3.47%
|
4,772,712
|
$22.04
|
$105,190,573
|
-20.15% (-1,204,132)
|
-0.86%
|
|
2024 Q3
|
3.50%
|
5,976,844
|
$18.02
|
$107,702,728
|
-11.60% (-784,602)
|
-0.47%
|
|
2024 Q2
|
3.66%
|
6,761,446
|
$16.25
|
$109,873,498
|
-9.78% (-733,244)
|
-0.37%
|
|
2024 Q1
|
3.31%
|
$14.11
|
-15.97% (-1,424,544)
|
|||
|
2023 Q4
|
3.23%
|
$10.44
|
+12.61% (+998,522)
|
|||
|
2023 Q3
|
3.09%
|
$10.20
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.